OIRA Conclusion of EO 12866 Regulatory Review

RIN: 0906-AB04         View EO 12866 Meetings Received Date: 04/09/2014 
Title: 340B Drug Pricing Program Regulations  
Agency/Subagency: HHS / HRSA  
Concluded Action: Withdrawn  Concluded Date: 11/13/2014 
Publication Date:  
Regulatory Flexibility Analysis Required: No  Small Entities Affected: No 
Federalism Implications: No  Affordable Care Act [Pub. L. 111-148 & 111-152]: No
International Impacts: No Dodd-Frank Wall Street Reform and Consumer Protection Act, [Pub. L. 111-203]: No
Pandemic Response: Uncollected